After Hours Summary: OCRX +23% on trial update, NVAX +9% continued strength/insider buy disclosure... MLHR -10%, JBL -4%, BBBY -1% following earnings/guidanceAfter Hours Gainers:
Companies trading higher in after hours in reaction to earnings/guidance:N/A
Companies trading higher in after hours in reaction to news: OCRX +22.5% (completes enrollment in STOP-ALF, a Phase 2a clinical trial to evaluate the Safety and Tolerability of Ornithine Phenylacetate in patients with Acute Liver Failure), AQXP +10.1% (Baker Bros increases active stake to 45.1%), URRE +9.6% (to acquire certain placer mining claims comprising the Sal Rica lithium brine project from Mesa Exploration), NVAX +8.8% (Director disclosed purchase of 100K shares, worth total of $144.9K; also follows today's 30%+ move higher), GALT +4.6% (continued strength following 35% move higher), IRBT +2.8% (light volume - awarded $23 mln US Navy contract modification), KDMN +2.1% (doses first patient in a Phase 2 clinical trial of KD025 for the treatment of chronic graft-versus-host disease; also initiates placebo-controlled Phase 2 clinical trial evaluating KD025 in Psoriasis), SRPT +1.1% (announces a $225 mln underwritten public offering of common stock), ADMP +0.6% (Adamis Pharma higher on light volume as Mylan CEO appears before Congress), SFLY +0.5% (modestly higher in after hours - attributed to Robert W. Baird suggesting today's move is overreaction to the new competing Amazon product)
After Hours Losers:
Companies trading lower in after hours in reaction to earnings/guidance: MLHR -9.9%, JBL -3.9% (also details restructuring plan, sees approximately $195 mln in pre-tax restructuring and other related costs), ALOG -3.3% (ticking lower), BBBY -1.1%
Companies trading lower in after hours in reaction to news: CPK -2% (light volume; files common stock shelf offering for an undisclosed amount; commences underwritten public offering of common stock with an aggregate value not to exceed $52 mln)